Why the study?
Although exercise training is recommended as a complementary treatment in POTS, less is known about how it can be successfully implemented in clinical practice.
Does a 16-week structured exercise programme improve symptom burden in patients with postural orthostatic tachycardia syndrome (POTS)?
Does a 16-week structured exercise programme improve symptom burden in patients with postural orthostatic tachycardia syndrome (POTS)?
This study protocol outlines a randomized cross-over trial to evaluate whether a 16-week supervised exercise program improves symptom burden and hemodynamics in patients with postural orthostatic tachycardia syndrome.
Should not change POTS care yet; leaves open whether this n=200 real-world program confirms exercise benefits.
INTRODUCTION: Exercise training is recommended as a complementary treatment in postural orthostatic tachycardia syndrome (POTS) according to international guidelines. However, less is known regarding how exercise training could successfully be implemented in clinical practice in patients with POTS. Thus, in the current study, we aim to assess the effect of a 16-week tailored exercise training programme in POTS. METHODS AND ANALYSIS: A total of 200 patients diagnosed with POTS will be recruited. The study will be conducted as a randomised cross-over study. POTS symptoms will be evaluated using the Malmö POTS Symptom Score, Orthostatic Hypotension Questionnaire and 36-item Short Form Health Survey. Haemodynamic parameters will be evaluated by orthostatic tests and maximum working capacity evaluated by bicycle exercise test. Symptoms, haemodynamic parameters and exercise capacity will be assessed before and after a 16-week training programme. ETHICS AND DISSEMINATION: The study was approved by the Swedish ethical review authority (2022-03186-01) and all procedures will be performed in accordance with the Helsinki Declaration. Results will be made available to patients with POTS, healthcare professionals, the funders and other researchers in publicly available (open access) medical journals. TRIAL REGISTRATION DETAILS: NCT05554107, registered on 26 September 2022.
No takes yet. Share an insight, caveat, or question.
Kharraziha et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: